Clinical Trial Update: Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial of decitabine with a vaccine therapy in relapsed/refractory pediatric high-grade gliomas, medulloblastoma, and CNS primitive neuroectodermal tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cns Primitive Neuroectodermal Tumor
• High-grade Glioma
• Medulloblastoma

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: University of Louisville | Conditions: Gliomas, Medulloblastoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-04-30